SLC13碳酸盐载体:功能,调节和人类疾病中的病理生理学影响
Ping Li1, Binxin Chen2, Minlei Dong3
1Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006 China.
Biochemical pharmacology
|January 25, 2026
概括
碳酸 (NaC) 载体家族促进细胞吸收关键代谢中间体. 这些载体的失调与代谢障碍,神经疾病和癌症等疾病有关.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 遗传学 遗传学 是一个
背景情况:
- SLC13基因家族编码了血膜载体,分为硫酸 (NaS) 和碳酸 (NaC) 携带载体.
- NaC子家族 (NaDC1,NaDC3,NaCT) 携带三碳酸循环中间体,作为代谢燃料和信号分子.
研究的目的:
- 审查结构生物学,基质特异性,组织分布和NaC载体调节方面的最新进展.
- 突出纳米甲基载体在人类疾病中的新出现的病理生理学意义.
主要方法:
- 文献综述综合了最近的研究发现.
- 对结构生物学,基质特异性,组织分布和调节机制的分析.
- 检查 NaC 载体调节失调与人类疾病之间的联系.
主要成果:
- 纳运输体在细胞吸收TCA循环中间体,如酸盐和酸盐中起着至关重要的作用.
- 纳运输体的失调与代谢障碍 (结石,脂肪肝病),神经疾病和癌症有关.
- 最近的进展为NAC传送器结构,功能和调节提供了洞察力.
结论:
- 了解 NaC 载体机制对于疾病病因学至关重要.
- 基于分子洞察力,可以开发针对NAC载体相关疾病的有针对性的治疗策略.
相关概念视频
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
Regulated mRNA Transport
3.4K
3.4K
Regulation of Sodium and Potassium
2.0K
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
2.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
190
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
190
Peptic Ulcer Disease II: Pathophysiology
2.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.6K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.6K


